Clinical Trial Update: Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of tranexamic acid on blood loss during reverse total shoulder arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Arthritis

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Shoulder Arthritis, Blood Loss, Surgical | Phase 3 | Status: WITHDRAWN